Legend Biotech Launches Inaugural ELITE Grant Program to Advance the Next Generation of CAR-T Innovation in Multiple Myeloma
Legend Biotech announced the launch of its inaugural ELITE grant program aimed at supporting early-career healthcare professionals advancing research, education, and innovation in CAR-T cell therapy for multiple myeloma. This annual initiative seeks to encourage novel approaches with funding awards and promotes leadership in the cellular therapy fi…